Biomarkers of Kidney Function in Transplant Medicine

NCT05538234 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-09-07

No results posted yet for this study

Summary

Biomarkers of kidney function in transplant medicine is an international, multicentre, observational, non-interventional study.

The project is aimed at monitoring biomarkers of acute kidney dysfunction in deceased organ donors, living organ donors, and organ recipients.

Conditions

Interventions

DIAGNOSTIC_TEST

Laboratory values - baseline

Baseline laboratory values will be obtained

OTHER

Medical information 12 hours before organ harvesting

* average hourly diuresis * hypotension MAP\<65 Torr longer than 30 minutes (YES/NO) * Furosemide administration (YES/NO) * Mannitol administration (YES/NO) * administration of anti-diuretic hormone (YES/NO) * administration of vasopressors (YES/NO) * polyuria \>3ml/kg/h (YES/NO) * nephrotoxic agents during hospitalization (YES/NO)

DIAGNOSTIC_TEST

Laboratory values - 12 hours after reperfusion

Laboratory values will be obtained 12 hours after reperfusion

DIAGNOSTIC_TEST

Laboratory values - 48 hours after reperfusion

Laboratory values will be obtained 48 hours after reperfusion

DIAGNOSTIC_TEST

Laboratory values - 7 days after reperfusion

Laboratory values will be obtained 7 days after reperfusion

DIAGNOSTIC_TEST

Laboratory values - 90 days after reperfusion

Laboratory values will be obtained 90 days after reperfusion

OTHER

Medical information during organ harvesting/transplantation

Medical information during organ harvesting/transplantation * hypotension MAP 65 Torr \> 5 minutes (YES/NO) * vasopressor support (YES/NO, duration in minutes)

PROCEDURE

Organ harvesting

Organ harvesting for transplant

PROCEDURE

Organ transplantation

Transplantation of the harvested organ

Sponsors & Collaborators

  • University Hospital Ostrava

    lead OTHER

Principal Investigators

  • Peter Sklienka, MD, Ph.D. · University Hospital Ostrava

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2025-12-31
Completion
2026-03-31

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05538234 on ClinicalTrials.gov